Christopher J. Kirk
Net Worth

Last updated:

What is Christopher J. Kirk net worth?

The estimated net worth of Dr. Christopher J. Kirk is at least $4,867,062 as of 20 Jul 2023. He owns shares worth $1,326,102 as insider and has received compensation worth at least $3,540,960 in Kezar Life Sciences, Inc..

What is the salary of Christopher J. Kirk?

Dr. Christopher J. Kirk salary is $590,160 per year as Co-Founder, Pres, Chief Scientific Officer & Director in Kezar Life Sciences, Inc..

How old is Christopher J. Kirk?

Dr. Christopher J. Kirk is 53 years old, born in 1972.

What stocks does Christopher J. Kirk currently own?

As insider, Dr. Christopher J. Kirk owns shares in one company:

Company Title Shares Price per share Total value
Kezar Life Sciences, Inc. (KZR) Co-Founder, Pres, Chief Scientific Officer & Director 342,609 $3.87 $1,326,102

What does Kezar Life Sciences, Inc. do?

Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States. The company's lead product candidate is KZR-616, a selective immunoproteasome inhibitor that is in Phase 2 clinical trials for various indications, including lupus nephritis, dermatomyositis, and polymyositis; and Phase 1b clinical trials in systemic lupus erythematosus and lupus nephritis. Its preclinical products include KZR-261, a novel first-in-class protein secretion inhibitor for the treatment of KZR-261; and KZR-TBD for the treatment of oncology and immunology. The company was incorporated in 2015 and is based in South San Francisco, California.

Christopher J. Kirk insider trading

Kezar Life Sciences, Inc.

Transaction Date Security Shares Price per share Total value Source
Option
Common Stock 48,950 $0.9 $44,055
Option
Employee Stock Option (right to buy) 48,950 $0.9 $44,055
Option
Common Stock 33,060 $0.9 $29,754
Option
Employee Stock Option (right to buy) 33,060 $0.9 $29,754
Purchase
Common Stock 38,461 $2.6 $99,999
Purchase
Common Stock 5,000 $4.61 $23,040
Purchase
Common Stock 5,000 $4.97 $24,830

Kezar Life Sciences key executives

Kezar Life Sciences, Inc. executives and other stock owners filed with the SEC: